United States

Securities and Exchange Commission

Washington, D.C. 20549

 

FORM 8-A

 

For registration of certain classes of securities

pursuant to section 12(b) or (g) of the

Securities Exchange Act of 1934

 

INSPIREMD, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware		26-2123838
(State of incorporation or organization)		(I.R.S. Employer Identification No.)

 

4 MENORAT HAMAOR ST., TEL AVIV		6744832
(Address of principal executive offices)		(Zip Code)

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class to be registered		Name of each exchange on which each class is to be registered
Series B Warrants, exercisable for one share of common stock		NYSE MKT LLC

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. [X]

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. [  ]

 

Securities Act registration statement file number to which this form relates: 333-215682

 

Securities to be registered pursuant to Section 12(g) of the Act: None.

 

 

 

Item 1. Description of Registrant’s Securities to be Registered.

 

InsireMD, Inc. (the “Registrant”) hereby incorporates by reference the description of its warrants to be registered hereunder contained under the heading “Description of Securities—Series B Warrants Being Issued in this Offering” in the Registrant’s prospectus dated March 9, 2017, filed by the Registrant on March 10, 2017, with the Securities and Exchange Commission (the “Commission”) pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended, in connection with the Registration Statement on Form S-1 (File No. 333-215682), as originally filed with the Commission on January 24, 2017, as subsequently amended.

 

Item 2. Exhibits.

 

See Index to Exhibits.

 

 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

	INSPIREMD, INC.
Date: April 4, 2017	By:	/s/ Craig Shore
		Name: Craig Shore
		Title: Chief Financial Officer

 

 

Exhibit Index

 

Exhibit No.		Description
1.		Series B Warrant Agreement, dated as of March 14, 2017, between InspireMD, Inc. and Action Stock Transfer Corporation, as Warrant Agent, which includes the form of Series B Warrant Certificate Stock as Exhibit A.